Researcher.Life Logo

Tuberculosis and Respiratory Diseases : Impact Factor & More

eISSN: 2005-6184pISSN: 1738-3536
JournalOpen Access

Key Metrics

CiteScore
5.1
H-Index
31
SJR
Q2Infectious Diseases
SNIP
1.08
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TAEHAN KYORHAEK HYOPHOE-KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASES
Language English
Frequency Quarterly
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorThe Korean Academy of Tuberculosis and Respiratory Diseases
FrequencyQuarterly
Publication Start Year1954
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 12
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Tuberculosis and Respiratory Diseases ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Tuberculosis and Respiratory Diseases

SERPINA3 as a Secreted-Protein Biomarker Associated with Poor Prognosis and T-cell Dysfunction in Non-Small Cell Lung Cancer.
  • 18 May 2026
  • Tuberculosis and respiratory diseases
Prevalence and Prognostic Impact of Progressive Pulmonary Fibrosis.
  • 15 May 2026
  • Tuberculosis and respiratory diseases
A harmonized respiratory-gut microbiome cohort framework for idiopathic pulmonary fibrosis.
  • 11 May 2026
  • Tuberculosis and respiratory diseases
Emerging targeted therapies in asthma: from upstream epithelial biology to novel biologic and small-molecule strategies.
  • 21 Apr 2026
  • Tuberculosis and respiratory diseases
Comparison of PROgnostic ModEl for chronic Lung disease (PRO-MEL) and ILD-GAP models in predicting mortality in Singaporean interstitial lung disease patients.
  • 13 Apr 2026
  • Tuberculosis and respiratory diseases
Linezolid-Induced Optic Neuritis in Tuberculosis: A Systematic Review of Case Reports, Case Series, and Cohort Studies.
  • 9 Apr 2026
  • Tuberculosis and respiratory diseases
SERPINA3 as a Secreted-Protein Biomarker Associated with Poor Prognosis and T-cell Dysfunction in Non-Small Cell Lung Cancer.
  • 18 May 2026
  • Tuberculosis and respiratory diseases
Prevalence and Prognostic Impact of Progressive Pulmonary Fibrosis.
  • 15 May 2026
  • Tuberculosis and respiratory diseases
A harmonized respiratory-gut microbiome cohort framework for idiopathic pulmonary fibrosis.
  • 11 May 2026
  • Tuberculosis and respiratory diseases
Emerging targeted therapies in asthma: from upstream epithelial biology to novel biologic and small-molecule strategies.
  • 21 Apr 2026
  • Tuberculosis and respiratory diseases
Comparison of PROgnostic ModEl for chronic Lung disease (PRO-MEL) and ILD-GAP models in predicting mortality in Singaporean interstitial lung disease patients.
  • 13 Apr 2026
  • Tuberculosis and respiratory diseases
Linezolid-Induced Optic Neuritis in Tuberculosis: A Systematic Review of Case Reports, Case Series, and Cohort Studies.
  • 9 Apr 2026
  • Tuberculosis and respiratory diseases

FAQs on Tuberculosis and Respiratory Diseases